Women with abnormal mammogram results got faster follow-up care if additional imaging was the next step than if doctors prescribed a biopsy or surgical consultation, according to a new study in the journal Radiology.
Women with abnormal mammogram results got faster follow-up care if additional imaging was the next step than if doctors prescribed a biopsy or surgical consultation, according to a new study in the journal Radiology. But most patients needing follow-up got it within three weeks of the recommendation, found researchers led by University of New Mexico radiologist Robert D. Rosenberg, MD.
Rosenberg and colleagues aimed to quantify the timeliness of follow-up care in community-based settings among women for whom radiologists recommended immediate follow-up. The team examined screening mammograms from Breast Cancer Surveillance Consortium patients 40 to 80 years old from 1996 to 2007. Researchers considered 214,897 recommendations for additional imaging from 118 facilities and 35,622 recommendations for biopsy or surgical consultation from 101 facilities.
The median time to follow-up was 14 days for additional imaging and 16 days for biopsy or surgical consultation, the researchers found, with about 90 percent of imaging follow-up and 81 percent of biopsy or surgical consultations happening within 30 days.
Facilities with higher recall rates generally had longer follow-up times. In general, the pace of consultation for biopsy and surgical consultations improved over the 11-year study.
Time to follow-up varied widely, and was linked to volume - though not the type of facility - suggesting potential for improvement for many of them, the researchers said.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?
April 10th 2025In a new study involving over 120 women, nearly two-thirds of whom had a family history of breast cancer, ultrafast MRI findings revealed a 5 percent increase in malignancy risk for each second increase in the difference between lesion and background parenchymal enhancement (BPE) time to enhancement (TTE).
AMA Approves Category III CPT Codes for AI-Enabled Perivascular Fat Analysis from CT Scans
April 9th 2025Going into effect in 2026, the new CPT codes may facilitate increased adoption of the CaRi-Heart software for detecting coronary inflammation from computed tomography scans pending FDA clearance of the technology.